Re: Exempt Distribution Jan 20

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Telepanel

Rank: Treasurer [?]

Points: 1140 [?]

Votes: 22 Score: 2.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Exempt Distribution Jan 20

in response to

Re: Exempt Distribution Jan 20

Telepanel

posted on Jan 30, 2021 09:11AM

AM I nuts this is the same stock at 1/3 price! Worth picking up a couple of k

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply